Form 144: 10,000 NBIX Shares Listed for Sale

Morgan Stanley Smith Barney LLC submitted a Form 144 notice for the proposed sale of 10,000 shares of Common Stock tied to an exercise of stock options with an execution method listed as cash and a filing date of 07/09/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice for the proposed sale of 10,000 shares of Common Stock tied to an exercise of stock options with an execution method listed as cash and a filing date of 07/09/2026. The excerpt also lists recent 10b5-1 sales by Darin Lippoldt totaling 9,800 shares on 06/29/2026 for $1,667,578.78 and 200 shares on 06/26/2026 for $33,913.00. The content shows 100,549,983 shares outstanding as of 07/09/2026.

Insights

Securities Compliance Expert

Form 144 records a proposed resale following option exercise and lists prior 10b5-1 sales.

The filing excerpt shows a dealer notice listing 10,000 shares to be sold on 07/09/2026 in connection with an exercise of stock options, with cash listed as the method. It separately reports pre-arranged 10b5-1 dispositions by Darin Lippoldt of 9,800 shares and 200 shares on 06/29/2026 and 06/26/2026, respectively.

The filing is procedural: it notifies the broker/dealer and SEC of an intended resale. Cash‑flow treatment and whether the issuer receives proceeds are not stated in the provided excerpt; subsequent filings or trade reports would show execution details.

Key Figures

Proposed resale: 10,000 shares Prior 10b5-1 sale: 9,800 shares Prior 10b5-1 sale: 200 shares +1 more

4 metrics

Proposed resale 10,000 shares Securities to be sold; exercise of stock options; <date>07/09/2026</date>

Prior 10b5-1 sale 9,800 shares Sale on <date>06/29/2026</date> for <money>$1,667,578.78</money>

Prior 10b5-1 sale 200 shares Sale on <date>06/26/2026</date> for <money>$33,913.00</money>

Shares outstanding 100,549,983 shares Outstanding as of <date>07/09/2026</date>

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"Filer Information | Securities To Be Sold line showing proposed resale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"Securities Sold During The Past 3 Months showing Darin Lippoldt sales"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold entry listing cause of proposed sale"

FAQ

What does the Form 144 for NBIX list as the proposed sale?

The notice lists a proposed sale of 10,000 shares of Common Stock tied to an exercise of stock options with method shown as cash on 07/09/2026. It is a dealer/issuer notice of resale.

Did anyone recently sell NBIX shares under a 10b5-1 plan?

Yes. The excerpt shows Darin Lippoldt executed 10b5-1 sales of 9,800 shares on 06/29/2026 for $1,667,578.78 and 200 shares on 06/26/2026 for $33,913.00. These are reported dispositions.

Who filed the Form 144 notice in the excerpt?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the filer for the proposed sale, located at the address shown in the excerpt, acting in a broker/dealer capacity.

How many NBIX shares are shown outstanding in the excerpt?

The content shows 100,549,983 shares outstanding as of 07/09/2026. This appears as a baseline figure in the excerpt's securities information table.

Does the Form 144 excerpt state who receives the sale proceeds?

The excerpt identifies the sale method as cash but does not state whether the issuer or a selling holder receives proceeds; cash‑flow treatment is not specified in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/09/2026 - 04:27 PM Accepted by SEC EDGAR 07/09/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001504783
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEUROCRINE BIOSCIENCES, INC.
SEC File Number	000-22705
Address of Issuer	6027 Edgewood Bend Court San Diego CALIFORNIA 92130
Phone	8586177600
Name of Person for Whose Account the Securities are To Be Sold	DARIN LIPPOLDT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1782400.00	100549983	07/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/09/2026	Exercise of Stock Options	Issuer			10000	07/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DARIN LIPPOLDT 6027 Edgewood Bend Court San Diego CA 92130	Common	06/29/2026	9800	1667578.78
10b5-1 Sales for DARIN LIPPOLDT 6027 Edgewood Bend Court San Diego CA 92130	Common	06/26/2026	200	33913.00

144: Remarks and Signature

Remarks
Date of Notice	07/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Darin Lippoldt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)